These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7878362)

  • 1. [Adjuvant chemotherapy in cancers of the colon and rectum].
    Bleiberg H
    Rev Prat; 1994 Dec; 44(20):2721-6. PubMed ID: 7878362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant treatment of colonic carcinoma].
    Rochlitz CF; Herrmann R
    Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for colorectal carcinoma.
    Kim R; Yamaguchi Y; Toge T
    Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant postoperative therapy of gastrointestinal malignancies.
    Ilson DH; Kelsen DP
    Oncology (Williston Park); 1994 Jul; 8(7):75-83; discussion 83, 88-90, 95. PubMed ID: 7917843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
    Kodaira S; Shatari T; Nozawa K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant therapy in colorectal cancer.
    Hesketh PJ; Bulger KN
    Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of chemotherapy in cancers of the colon].
    Seitz JF; Rougier P
    Bull Cancer; 1994 Apr; 81(4):260-76. PubMed ID: 7535602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.
    Skillings JR; Levine M; Rayner HL; Eisenhauer E; Erlichman C; Germond C; Kerr I; Lofters W; Maroun J; Yoshida S
    CMAJ; 1991 Feb; 144(3):297-301. PubMed ID: 1989708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress of adjuvant chemotherapy in colon cancer].
    Toge T
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):554-9. PubMed ID: 8678512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
    Bokemeyer C; Hartmann JT; Kanz L
    Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for adjuvant therapy in bowel cancer?
    Marsh JC
    J Clin Gastroenterol; 1994 Apr; 18(3):184-8. PubMed ID: 8034911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy in colorectal cancer.
    Büyükünal E; Berkarda N; Serdengeçti S; Derman U; Berkarda B
    Chemioterapia; 1986 Oct; 5(5):337-40. PubMed ID: 3791482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
    Rougier P; Nordlinger B
    Ann Oncol; 1993; 4 Suppl 2():21-8. PubMed ID: 8353101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.